Core B. This Core will provide three separate but highly integrated functions, with each component representing a critical element to the P01's Projects. First is a biorepository function;a unit within the University of Florida's NIH funded CTSI Biorepository. Here, the Core will validate proper patient consenting, tissue procurement, sample processing, storage and distribution. Core B will ensure that high quality specimens are obtained through adherence to GLP procedures, computerized sample tracking, biobanking best practices, automated storage, as well as emergency response planning by trained staff. The Core will routinely store samples collected as part of the Program, including serum, plasma, PBMCs, DNA, RNA and urine (if ever deemed necessary). The samples will be securely managed using web-based software including the OnCore Biospecimen Management System that tracks patient consent, patient visits, collection and annotation of specimens, specimen processing, storage, quality assurance and distribution of samples. With this, the Core should provide Projects 1 and 2 with a uniformly processed aliquot of a sample in order to optimize multivariate analysis of data across the Program. A second activity for this Core involves service by the Immunology/Pathology Laboratory. Here, as a routine analysis for subjects enrolled in this study, the Core will provide autoantibody (i.e., GADA, IA-2A, and ZnT8A) analysis using commercially available kits, and mlAA by standard assay. The Core's performance in the Diabetes Autoantibody Standardization Program routinely scores with high sensitivity/specificity. Additional services will include HLA typing and overseeing the highly innovative immunochip analysis. Finally, the Core will provide Molecular Pathology services. This laboratory serves as a key element to the JDRF Network for Pancreatic Organ donors with Diabetes (nPOD) effort. Core B will provide paraffin and frozen section preparation, histology, quantitative morphology, immunolocalization (IHC, IF, ISH) and e-storage of microscopic images. We see Core B as both an innovative and highly valuable unit only available through a PPG Core mechanism.

Public Health Relevance

Core B will provide quality samples, as well as a comprehensive laboratory data storage/analysis function;both deemed essential to high quality research. In addition, the Core has established standard operating procedures (GLP grade) and trained personnel to ensure high quality performance. Core activities will also help integrate Projects within the POI;increasing its value and potential to deliver on its goals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI042288-15A1
Application #
8566446
Study Section
Special Emphasis Panel (ZAI1-PA-I (M1))
Project Start
Project End
Budget Start
2013-05-10
Budget End
2014-04-30
Support Year
15
Fiscal Year
2013
Total Cost
$176,062
Indirect Cost
$57,899
Name
University of Florida
Department
Type
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Haller, Michael J; Gitelman, Stephen E; Gottlieb, Peter A et al. (2016) Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes. Diabetes 65:3765-3775
Delitto, Daniel; Delitto, Andrea E; DiVita, Bayli B et al. (2016) Human pancreatic cancer cells induce a MyD88-dependent stromal response to promote a tumor-tolerant immune microenvironment. Cancer Res :
Seay, Howard R; Yusko, Erik; Rothweiler, Stephanie J et al. (2016) Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes. JCI Insight 1:e88242
Bian, Xiaofang; Wallstrom, Garrick; Davis, Amy et al. (2016) Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays. Diabetes 65:285-96
Campbell-Thompson, Martha L; Kaddis, John S; Wasserfall, Clive et al. (2016) The influence of type 1 diabetes on pancreatic weight. Diabetologia 59:217-21
Babon, Jenny Aurielle B; DeNicola, Megan E; Blodgett, David M et al. (2016) Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat Med 22:1482-1487
Battaglia, Manuela; Atkinson, Mark A (2015) The streetlight effect in type 1 diabetes. Diabetes 64:1081-90
Haller, Michael J; Gitelman, Stephen E; Gottlieb, Peter A et al. (2015) Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. J Clin Invest 125:448-55
Oleson, Bryndon J; McGraw, Jennifer A; Broniowska, Katarzyna A et al. (2015) Distinct differences in the responses of the human pancreatic β-cell line EndoC-βH1 and human islets to proinflammatory cytokines. Am J Physiol Regul Integr Comp Physiol 309:R525-34
Ulmer, Candice Z; Yost, Richard A; Chen, Jing et al. (2015) Liquid Chromatography-Mass Spectrometry Metabolic and Lipidomic Sample Preparation Workflow for Suspension-Cultured Mammalian Cells using Jurkat T lymphocyte Cells. J Proteomics Bioinform 8:126-132

Showing the most recent 10 out of 90 publications